Pastan I - Search Results

1

Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40. Inhibition of experimental autoimmune uveoretinitis.

Roberge FG, Lorberboum-Galski H, Le Hoang P, de Smet M, Chan CC, Fitzgerald D, Pastan I. Roberge FG, et al. Among authors: pastan i. J Immunol. 1989 Dec 1;143(11):3498-502. J Immunol. 1989. PMID: 2511243

2

Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor.

Kreitman RJ, Schneider WP, Queen C, Tsudo M, Fitzgerald DJ, Waldmann TA, Pastan I. Kreitman RJ, et al. Among authors: pastan i. J Immunol. 1992 Oct 15;149(8):2810-5. J Immunol. 1992. PMID: 1401913

3

In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin.

Puri RK, FitzGerald D, Leland P, Kozak RW, Pastan I. Puri RK, et al. Among authors: pastan i. Cell Immunol. 1992 Sep;143(2):324-34. doi: 10.1016/0008-8749(92)90029-o. Cell Immunol. 1992. PMID: 1511480

4

Immunospecific suppression of encephalitogenic-activated T lymphocytes by chimeric cytotoxin IL-2-PE40.

Beraud E, Lorberboum-Galski H, Chan CC, FitzGerald D, Pastan I, Nussenblatt RB. Beraud E, et al. Among authors: pastan i. Cell Immunol. 1991 Apr 1;133(2):379-89. doi: 10.1016/0008-8749(91)90112-o. Cell Immunol. 1991. PMID: 1707763

5

Treatment of corneal allograft rejection with the cytotoxin IL-2-PE40.

Herbort CP, de Smet MD, Roberge FG, Nussenblatt RB, FitzGerald D, Lorberboum-Galski H, Pastan I. Herbort CP, et al. Among authors: pastan i. Transplantation. 1991 Sep;52(3):470-4. doi: 10.1097/00007890-199109000-00015. Transplantation. 1991. PMID: 1897019

6

Redirecting Pseudomonas exotoxin.

FitzGerald D, Pastan I. FitzGerald D, et al. Among authors: pastan i. Semin Cell Biol. 1991 Feb;2(1):31-7. Semin Cell Biol. 1991. PMID: 1954341 Review.

7

Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusion.

Lorberboum-Galski H, Lafyatis R, Case JP, FitzGerald D, Wilder RL, Pastan I. Lorberboum-Galski H, et al. Among authors: pastan i. Int J Immunopharmacol. 1991;13(2-3):305-15. doi: 10.1016/0192-0561(91)90112-k. Int J Immunopharmacol. 1991. PMID: 2071302

8

Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.

Siegall CB, FitzGerald DJ, Pastan I. Siegall CB, et al. Among authors: pastan i. J Biol Chem. 1990 Sep 25;265(27):16318-23. J Biol Chem. 1990. PMID: 2118904 Free article.

9

Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-IL-2 receptor (Tac) monoclonal antibody.

Kozak RW, Fitzgerald DP, Atcher RW, Goldman CK, Nelson DL, Gansow OA, Pastan I, Waldmann TA. Kozak RW, et al. Among authors: pastan i. J Immunol. 1990 May 1;144(9):3417-23. J Immunol. 1990. PMID: 2139454

10

IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.

Kozak RW, Lorberboum-Galski H, Jones L, Puri RK, Willingham MC, Malek T, Fitzgerald DJ, Waldmann TA, Pastan I. Kozak RW, et al. Among authors: pastan i. J Immunol. 1990 Oct 15;145(8):2766-71. J Immunol. 1990. PMID: 2212661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,282 results

Search Page

Filters